Yendo, T.M.; Sato, M.N.; Branco, A.C.C.C.; Pietrobon, A.J.; Teixeira, F.M.E.; Ramos, Y.Á.L.; Alberca, R.W.; Valêncio, C.G.; Arruda, V.N.; Romiti, R.;
et al. Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines 2021, 9, 478.
https://doi.org/10.3390/vaccines9050478
AMA Style
Yendo TM, Sato MN, Branco ACCC, Pietrobon AJ, Teixeira FME, Ramos YÁL, Alberca RW, Valêncio CG, Arruda VN, Romiti R,
et al. Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines. 2021; 9(5):478.
https://doi.org/10.3390/vaccines9050478
Chicago/Turabian Style
Yendo, Tatiana Mina, Maria Notomi Sato, Anna Cláudia Calvielli Castelo Branco, Anna Julia Pietrobon, Franciane Mouradian Emidio Teixeira, Yasmim Álefe Leuzzi Ramos, Ricardo Wesley Alberca, Cesar Giudice Valêncio, Vivian Nunes Arruda, Ricardo Romiti,
and et al. 2021. "Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19" Vaccines 9, no. 5: 478.
https://doi.org/10.3390/vaccines9050478
APA Style
Yendo, T. M., Sato, M. N., Branco, A. C. C. C., Pietrobon, A. J., Teixeira, F. M. E., Ramos, Y. Á. L., Alberca, R. W., Valêncio, C. G., Arruda, V. N., Romiti, R., Arnone, M., Hirayama, A. L. d. S., Duarte, A. J. d. S., Aoki, V., & Orfali, R. L.
(2021). Impact of Inflammatory Immune Dysfunction in Psoriasis Patients at Risk for COVID-19. Vaccines, 9(5), 478.
https://doi.org/10.3390/vaccines9050478
